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ABSTRACT 
Purpose: Elevated cholesterol is known to be associated with chronic kidney disease 
(CKD) and cardiovascular disease (CVD) independently. Cardiorenal syndrome (CRS), a recently 
defined syndrome, is characterized by renal failure that is closely interrelated to cardiac 
dysfunction. The effect of socioeconomic status on cardiorenal syndrome has not been explored 
in a multi-ethnic population. In this retrospective secondary analysis, the hypothesis was tested if 
socioeconomic status modifies the effect of hyperlipidemia on CRS. 
Methods: The National Health and Nutrition Examination Survey (NHANES) is a cross 
sectional survey done on the non-institutionalized population of the United States. All patients 
from the NHANES study, 20 years and older between the years 1999-2010 were included in the 
analysis. CRS was determined using a standard GFR equation and history of CVD. Analysis was 
performed using complex samples logistic regression to determine the relationship of 
hyperlipidemia on CRS. 
Results: Data on CRS status was available for 24,625 individuals (48.9% males & 51.1% 
females) and was representative of 173,805,863 individuals. The overall unadjusted odds ratio of 
CRS for hyperlipidemia to no hyperlipidemia was 3.01 (95% confidence interval [CI], 2.62-3.47, 
p < 0.001). The adjusted OR was elevated, 2.20 (CI 1.20-4.05, p < 0.01), among individuals living 
below poverty threshold but close to 1.0 (1.63 CI 1.31-2.03, p < 0.001) among patients above 
poverty threshold, after the results were controlled for medical risk factors and demographic risk 
factors. 
Conclusions: Hyperlipidemia is strongly associated with CRS in a nationally 
representative multi-ethnic population and must be taken into special consideration when treating 
underprivileged patients. Longitudinal studies should further examine this association and 
demonstrate how socioeconomic status plays a role. 
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30  Effect of Poverty Level on the Relationship between Hyperlipidemia and Cardiorenal 
Syndrome 
Banerjee et al. 
 
Journal of Health Disparities Research and Practice Volume 13, Issue 1, Spring 2020 
 http://digitalscholarship.unlv.edu/jhdrp/    
Follow on Facebook:  Health.Disparities.Journal 
Follow on Twitter:  @jhdrp 
 
INTRODUCTION 
Understanding chronic diseases through the lens of upstream factors like poverty and social 
disparities is an integral part of preventive medicine (Aikens & Piette, 2009; Overland, Hoskins, 
McGill, & Yue, 1993; Krishnaswami, Jaini, Howard, Ghaddar, 2018; Rutter et al., 2017).  
Managing and diagnosing hyperlipidemia is a standard of care to effectively prevent chronic 
kidney disease (CKD) and cardiovascular disease (CVD) (Althemery, Lai, & Alfaifi, 2015; 
Tarride, 2009).  Hyperlipidemia refers to elevated cholesterol, elevated triglycerides, or both.  
Much of the work in chronic disease has focused on lifestyle changes; however, social 
determinants of health may provide a better understanding of why these lifestyle changes are not 
improving health outcomes (Althemery, Lai, & Alfaifi, 2015; Tarride, 2009).  Rather than 
examining socioeconomic status individually, most researchers control for this variable.  The lack 
of research on social determinants of health associated with cardiorenal syndrome demonstrates 
that there is a need for understanding whether these factors have direct or indirect effects and what 
the mechanism’s underlying associations may be. The psychological demands of chronic diseases 
suggest that a pathway may exist, but more work is needed to overcome the current gaps in 
knowledge (Walker, Gebregziabher, Martin-Harris, & Egede, 2014). 
Hyperlipidemia is a major cause of morbidity in the worldwide, causing cardiovascular and 
renal dysfunction simultaneously. Consequently, cardiorenal syndrome (CRS) is closely related 
complication of hyperlipidemia and is associated with increased mortality, growing complications, 
and increased cost of care (Flores, Chavez, Bolger, & Casad, 2018; Krishnaswami, Jaini, Howard, 
& Ghaddar, 2018; Liang et al., 2018; Taylor et al., 2017; Walker et al., 2014; Williams et al., 2018; 
Zeng et al., 2018). Cardiorenal syndrome can be defined as a bidirectional pathological impairment 
of either the heart or the kidney as a result of acute or chronic primary dysfunction in either organ 
(Banerjee & Panas, 2017; Lekawanvijit et al., 2012; Ronco, House, & Haapio, 2008; Stucker & 
Saudan, 2013; Virzi, Clementi, Battaglia, & Ronco, 2019).  Depending on the primary organ 
affected and the acuteness of the condition, this syndrome constitutes five subtypes (Banerjee et 
al., 2017; Virzi et al., 2019).  Hyperlipidemia is associated with CKD development due to renal 
artery sclerosis and nephroangiosclerosis and a faster rate of CKD progression.  Additionally, 
dyslipidemia is associated with CVD and more mortality due to cardiovascular disease than end 
stage renal disease (ESRD) (Machado et al., 2018; Usui et al., 2017).  More specifically low high-
density lipoprotein (HDL) cholesterol and elevated non-HDL cholesterol are associated to a two-
fold risk of renal insufficiency after adjustment for other risk factors (Usui et al., 2017). The risk 
of microvascular complications can be reduced by control of hyperlipidemia through statins, 
whereas benefit to CRS is less clear.   
The precise connection between socioeconomic status and lipid status is unknown.  
Specifically, the effect of hyperlipidemia on CRS has not been explored in a nationally 
representative multi-ethnic population previously, especially in the context of social disparities. In 
this retrospective secondary analysis, the hypothesis was tested if poverty level has an effect on 
lipid status and if poverty level modifies the effect of hyperlipidemia on CRS.   
 
METHODS 
 The National Health and Nutrition Examination Survey (NHANES) is a cross sectional 
survey done on the non-institutionalized population of the United States by the Center for Disease 
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Control and Prevention and National Center for Health Statistics.  All patients from the nationally 
representative NHANES study, 20 years and older between the years 1999-2010 were included in 
the analysis.   
Presence of cardiorenal syndrome was designated by determining the presence of CKD 
and CVD.  Glomerular filtration rate (GFR) was derived from the Cockcroft-Gault equation.  For 
the purposes of this study, a GFR of less than 60 mL/min per 1.73 m2 was considered to be CKD 
as previously validated.  Even though, technically, a GFR less than 90 mL/min per 1.73 m2 is 
considered CKD, the high number from advanced age places most people with a high age in either 
Stage I or Stage II CKD.  CVD was determined by the self-reported diagnosis of coronary heart 
disease, angina, stroke, Congestive Heart Failure (CHF), and heart attack.    
All respondents over the age of 20 were asked “Other than during pregnancy, have you 
ever been told by a doctor or other health professional that you have diabetes or sugar diabetes?”.   
For the purposes of this study, the participants who answered “borderline” or “yes” was considered 
as having diabetes.  However, those participants who answered “no” was considered as non-
diabetic.  
Below poverty threshold was considered when poverty-income ratio less than one.  This is 
equivalent to less than 100% of the Federal Poverty Level.  Poverty-income Ratio (PIR) greater 
than or equal to 1 was considered above poverty threshold. 
Each respondent was asked about their cholesterol status. Hyperlipidemia was defined by 
the respondent answering “yes” to being told of having high cholesterol, was taking cholesterol-
lowering drugs, or had a cholesterol level of 240 mg/dL or higher.  The rest of the subjects were 
ascertained as not having high cholesterol. 
The smoking data was subdivided into a two-variable indicator as a smoker versus never 
smoker.  The subject was considered a “smoker” if s/he reports “yes” to the question, “Have you 
smoked at least 100 cigarettes in your entire life?” and did not answer “not at all” to the question, 
“Do you now smoke cigarettes…” in the NHANES 1999–2010.  Any answers by the participants 
such as “don’t know”, “refuse”, or “not sure” was recorded as missing data and was not be included 
in the data analyses.  In order to ascertain the race/ethnicity of the subject, the interviewer asked 
“What race do you consider yourself to be?”  Within the NHANES questionnaire, respondents 
were allowed to select one out of five categories. The different categories were coded as follows: 
Non-Hispanic White, Non-Hispanic Black, Hispanic, and Other.   
Hs-CRP was quantified by using latex-enhanced nephelometry, and a high-sensitivity 
assay was performed on a Behring (Deerfield, IL) nephelometer.  The lower limit of detection for 
this test was 0.2 mg/L. For continuous analyses, all values of 0.2 mg/L were coded as equal to 0.1. 
Research in adults has indicated increased risk of cardiovascular disease beginning at values of > 
2.0 mg/L, so this value was used as a cut point for analysis (Ridker, 2003; Ridker et al., 2005).  
Values of hs-CRP < 1.0 mg/L was considered as cardiovascular risk, and the rest was not. 
Before data collection for NHANES, the NCHS received approval from the NCHS 
Research Ethics Review Board (changed from the Institute Review Board), continuance of the 
protocol #2011-17.  The NCHS complies strictly with the different laws and regulations which are 
written with the intent of protecting the specific participant’s confidentiality and safety. 
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Study Population 
All non-institutionalized patients from the nationally representative NHANES study, 20 
years and older between the years 1999-2010 were included in the analysis.  This study is 
especially needed in a national population as broad policy guidelines are needed at a national level. 
Statistical analysis 
Continuous variables were described as both mean ± standard deviation (SD). Normal 
distributions of values were assessed by using the Shapiro-Wilk test. Categorical variables were 
expressed as percentage values and analyzed using chi-square testing. Analysis was performed 
using complex samples logistic regression to determine relationship of hypercholesterolemia on 
CRS.   Complex samples multiple logistic regression models were used to examine below-above 
poverty line patient differences after adjusting for sociodemographic and health factors, estimating 
variances using the Taylor series linearization method.  All missing variables were excluded. All 
statistical analysis was performed in SAS 9.2 and SPSS 21.0. 
 
RESULTS  
Data was available for 12,332 individuals (53% females vs. 47% males). Table 1 provides 
data on the distribution of demographic characteristics of the participants by socioeconomic status 
using bivariate analysis. The prevalence of CRS in US population in the age group between 20-85 
was 5.1%. The average age of participants with CRS was 73.4 ± 0.28. There was statistically 
significant (p<0.05) association between poverty level and obesity, cholesterol, diabetes, gender, 
age, race/ethnicity, and CRP status.  There were significantly more females (61.7%) with PIR < 1 
than females (51.6%) with PIR ≥ 1, as seen in Table 1.  Among Non-Hispanic Blacks, the 
percentage with PIR < 1 (17.3%) was higher than PIR ≥ 1 (9.0%).  A similar pattern was observed 
among the Hispanic population.  
In addition to the basic demographic descriptive statistics, the following variables that may 
be associated with socioeconomic status are presented in Table 1.  Based on bivariate analyses, 
more individuals with PIR < 1 (14.1%) had diabetes than individuals with PIR ≥ 1 (9.9%).  Also, 
among smokers, more individuals had PIR < 1 (52.5%) than individuals with PIR ≥ 1 (44.9%).  
Finally, when assessing C-reactive protein, individuals with PIR < 1 (5.0%) had higher rates of 
high CRP than those in PIR ≥ 1 (2.5%). 
33  Effect of Poverty Level on the Relationship between Hyperlipidemia and Cardiorenal 
Syndrome 
Banerjee et al. 
 
Journal of Health Disparities Research and Practice Volume 13, Issue 1, Spring 2020 
 http://digitalscholarship.unlv.edu/jhdrp/    
Follow on Facebook:  Health.Disparities.Journal 
Follow on Twitter:  @jhdrp 
Table 1. Baseline Clinical Characteristics of Study Participants stratified by Poverty-to-Income 
Ratio 
Variable Total population 
(n=12,332) 
PIR ≥ 1 
(n=9,565) 
PIR < 1 
(n=1,740) 
Demographic Risk Factors 
Female** 52.7% 51.6% 61.7% 
Mean age (SE) 48.5 (0.21) 48.6 (0.19) 45.4 (0.28) 
Ethnicity**    
   Non-Hisp. White 74.1% 77.3% 50.6% 
   Non-Hisp. Black 9.9% 9.0% 17.3% 
   Hispanic 10.8% 8.8% 25.2% 
   Other 5.2% 4.9% 6.9% 
CRS Risk Factors 
CRP Levels (μg/ml)**    
  Low (<1) 90.3% 90.7% 84.9% 
  Intermediate (1-2) 6.9% 6.8% 10.1% 
  High (>2) 2.7% 2.5% 5.0% 
Diabetes** 10.4% 9.9% 14.1% 
Smoking Status    
  Smoker 45.9% 44.9% 52.5% 
  Non-Smoker 54.1% 55.1% 47.5% 
Obesity Status**    
  Non-obese 62.5% 63.0% 52.3% 
  Obese  37.5% 37.0% 13.4% 
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Hyperlipidemia** 37.8% 37.0% 41.4% 
**p < 0.05 
 
As seen in Table 2, significant predictors to CRS among patients above poverty threshold 
(PIR ≥ 1) were patients: with diabetes (OR= 2.71; CI= 1.55-4.73), with hyperlipidemia (OR= 1.63; 
CI=1.31-2.01), without obesity (OR= 0.61; CI=0.48-0.77), high CRP (OR=2.14; CI=1.28-2.58), 
Non-Hispanic Black race (OR=1.58; CI=1.17-2.13, male sex (OR= 1.30; CI=1.01-1.68) and 
increased age  (OR= 1.19; CI= 1.17-1.21).  As seen in Table 3, significant predictors to CRS among 
patients below poverty threshold (PIR < 1) were patients: with diabetes (OR= 3.92; CI= 2.95-
5.22), with hyperlipidemia (OR= 2.20; CI=1.20-4.05), Non-Hispanic Black race (OR=2.71; 
CI=1.43-5.16), and increased age (OR= 1.11; CI= 1.08-1.14). 
Differential effect of poverty level on CRS 
Specifically, there is a differential effect observed of poverty level on hyperlipidemia and 
ethnicity.  The overall unadjusted odds ratio of CRS for hyperlipidemia to no hyperlipidemia was 
3.01 (95% confidence interval [CI], 2.62-3.47, p < 0.001). As seen on Table 2 and Table 3, the 
adjusted OR was elevated, 2.20 (CI 1.20-4.05, p < 0.01), among individuals living below poverty 
(PIR < 1) threshold but close to 1.0 (1.63 CI 1.31-2.03, p < 0.001) among patients above poverty 
threshold (PIR ≥ 1), after the results were controlled for medical (obesity, smoking status, diabetes, 
and C-reactive protein) risk factors and demographic (ethnicity, gender, and age) risk factors.  
Additionally, the adjusted OR of CRS to no CRS among Non-Hispanic Blacks was elevated, 2.71 
(CI 1.43-5.16, p < 0.001), among individuals living below poverty (PIR < 1) threshold but close 
to 1.0 (1.58 CI 1.17-2.13, p < 0.05) among patients above poverty threshold (PIR ≥ 1), after the 
results were controlled for medical (obesity, smoking status, diabetes, and C-reactive protein) risk 
factors and demographic (ethnicity, gender, and age) risk factors.   
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Table 2: Multiple regression analysis between Hyperlipidemia and CRS in those individuals with 
Poverty-Income-Ratio ≥ 1. 
 95% Confidence 
Interval 
 
Variable B Lower Upper P 
Diabetes 2.71 1.55 4.73 <0.001 
Hyperlipidemia (mg/dL) 
(Reference: LDL<240) 
1.63 1.31 2.03 <0.001 
Obesity 
(Reference: BMI<30) 
0.61 0.48 0.77 <0.001 
Smoking Status  
(Reference: Never 
Smoker) 
0.86 0.68 1.08 0.198 
C-reactive protein 
(μg/ml) 
    
  Low (<1) Reference Reference Reference Reference 
  Intermediate (1-2) 1.57 1.03 2.38 0.005 
  High (>2) 2.14 1.28 2.58 0.005 
Ethnicity 
  Non-Hisp. White Reference Reference Reference Reference 
  Non-Hisp. Black 1.58 1.17 2.13 0.017 
  Hispanic 0.94 0.606 1.45 0.017 
  Other 1.41 0.60 3.28 0.017 
Gender 
(Reference:Female) 
1.30 1.01 1.68 0.042 
Age 1.19 1.17 1.21 <0.001 
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Table 3: Multiple regression analysis between Hyperlipidemia and CRS in those individuals with 
Poverty-Income-Ratio < 1. 
 95% Confidence Interval  
Variable B Lower Upper P 
Diabetes 3.92 2.95 5.22 <0.001 
Hyperlipidemia (mg/dL) 
(Reference: LDL<240) 
2.20 1.20 4.05 0.010 
Obesity 
(Reference: BMI<30) 
0.66 0.40 1.09 0.106 
Smoking Status  
(Reference: Never Smoker) 
0.73 0.40 1.36 0.319 
C-reactive protein (μg/ml)     
  Low (<1) Reference Reference Reference Reference 
  Intermediate (1-2) 0.77 0.37 1.62 0.283 
  High (>2) 1.82 0.81 4.08 0.283 
Ethnicity 
  Non-Hisp. White Reference Reference Reference Reference 
  Non-Hisp. Black 2.71 1.43 5.16 <0.001 
  Hispanic 0.86 0.45 1.64 0.001 
  Other 0.15 0.03 0.85 0.001 
Gender (Reference:Female) 1.10 0.56 2.17 0.777 




Hyperlipidemia is a significant comorbidity which brings significant complications to the 
prognosis of CKD and CHF simultaneously (Althemery et al., 2015).  The novel finding in this 
study was that lipid status is associated with socioeconomic status in a nationally representative 
population.  This finding has been corroborated in other studies conducted from the National 
Cardiovascular Data Registry's Practice Innovation and Clinical Excellence (PINNACLE) 
Registry.  The reason may be due to differential medication access or access to lipid-lowering diet 
depending on the level of income (Tanguturi et al., 2019)   
Also, in this study, we found that there was a strong association between hyperlipidemia 
and CRS.  According to our findings, individuals who have hyperlipidemia and low socioeconomic 
status (less than 100% of Federal Poverty Guidelines) have 320% higher likelihood of developing 
CRS than those that do not have hyperlipidemia in our nationally representative sample.  Previous 
researchers have found hyperlipidemia and socioeconomic status individually have an impact on 
cardiovascular disease (Ahmed et al., 2018; Cain, Glover, Young, & Sims, 2018; Heidenreich et 
al., 2011; Ma, Wang, Liu, & Cao, 2016; Xu, 2018).  Additionally, hyperlipidemia and 
socioeconomic status has an effect on CKD.  According to researchers analyzing the Jackson Heart 
Study, Cain et al. (2018) found that stress was related to the development of CKD.  Due to acute 
and chronic stress through allostatic load affecting the hypothalamic-pituitary-adrenal axis, 
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socioeconomic status has repeatedly been tied to chronic disease (Christensen, Flensborg-
Madsden, Garde, Hansen, Pedersen, Mortensen, 2018; Xu, 2018).   More specifically cortisol has 
been connected with psychoneuroendocrine dysfunction which is a by-product of chronic stress 
from living in poverty (Christensen et al., 2018).  Low socioeconomic status has been associated 
with many other diseases as well (Walker, Williams, & Egede, 2016; Hannibal & Bishop, 2014). 
Additionally, other CRS risk factors affect individuals living below poverty level status 
differently than those living at or above poverty level.  Specifically, when assessing known 
differences in CRS risk factors, we found that there was a statistically significant association 
observed between C-reactive protein among individuals below poverty level.   
Similarly, ethnicity had a differential effect in the hyperlipidemia versus CRS model 
among individuals in low socioeconomic status versus individuals in high socioeconomic status.  
More specifically, according to our study, Non-Hispanic Blacks living below poverty had higher 
odds of CRS among those with hyperlipidemia than those without.  This is alarming because 
African Americans require dialysis or transplant at younger ages and have greater incidence rates 
of end stage renal disease (ESRD) at each decade of life as compared to any other racial/ethnic 
group (Cain et al., 2018; De Moraes, Carvalho, McClelland, Diez-Roux, Szklo, 2018; Inman et 
al., 2016; Marmot & Allen, 2014; Vart et al., 2018).  Health care practitioners need to be made 
aware of how social determinants of health affects CRS (Cockerham, Hamby, & Oates, 2017; 
Joshi, John, & Jha, 2017; Kang et al., 2018; Norris, Nicholas, García-García, Agodoa, 2017; 
Phillips et al., 2018). According to our study, individuals who have CVD and diabetes have a 125% 
higher likelihood of developing CKD than those that do not have CVD, after controlling for CVD 
related risk factors in a multi-ethnic population.   
There were multiple limitations in this study.  First of all, this is a cross-sectional study, 
making it difficult to establish causation without reasonable doubt (Lê-Scherban et al., 2018).  
More longitudinal studies need to be done to understand the precise role of diabetes in the context 
of CRS.  Additionally, many times self-reported data may suffer from recall bias or social 
desirability bias.  However, wherever possible, we cross-checked self-reported data with 
laboratory tests. 
The study has several strengths.  This study is the first to demonstrate on a national level 
that hyperlipidemia is more strongly associated with cardiorenal syndrome in individuals with low 
socioeconomic status than in a high socioeconomic status.  Due to the study design, the association 
can be generalized to the national level.  Additionally, there are differential risk factors between 
low and normal socioeconomic status as is pertain cardiorenal syndrome.  Demonstrating risk 
factors of cardiorenal syndrome is important as this is a typical endpoint for several chronic 
diseases like cardiovascular disease, diabetes, and congestive heart failure. 
Future Research and Practical Recommendations  
 In light of cyclical economic downturns, it is increasingly important to understand the 
health effects of varying poverty levels.  Recently, with the global impact of COVID-19, many 
individuals are experiencing poverty and limited access to preventative care.  Future policy should 
be tailored to address economic disparities in the population so that modifiable risk factors can be 
mitigated.  Potential disparities in access to care should be addressed by identifying important 
barriers experienced by the poor. 
In our study, it is unclear why income level modifies the impact that lipid status has on the 
development of CRS.  One possibility is that hyperlipidemia may have an interaction with 
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adrenergic overactivity and corticoadrenal activity especially among those with chronic emotional 
stress (Lopez-Cepero et al., 2020).  Chronic stress has been shown to be experienced by those who 
are poor.  These potential connections can be assessed through further physiological or fMRI 
studies.  Additionally, the precise longitudinal connections should be explored using interaction 
studies between income status and lipid status.  This will help establish causation more strongly. 
 
CONCLUSION 
 Chronic diseases risk factors are different according to the socioeconomic disparities of the 
population.  Specifically, lipid metabolism is important as it pertains to chronic diseases like 
cardiorenal syndrome.  However, when considering poverty and low socioeconomic status, 
hyperlipidemia has a differential effect on the group.  More studies need to explore which risk 
factors are important as it pertains to specific socioeconomic status.  Policies from the 
governmental level need to address health inequity and provide resources and education for 
individuals in different socioeconomic status.  Self-management and better coordination of care 
needs to take place in this subpopulation as well. 
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